Related Experiment Video
Updated: Jul 16, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
[Newborn infants supported by extracorporeal membrane oxygenation: survival and clinical outcome]
Insights
Extracorporeal membrane oxygenation (ECMO) offers a favorable prognosis for newborns with severe respiratory failure, with low long-term morbidity despite initial challenges. Long-term outcomes for congenital diaphragmatic hernia (CDH) infants are generally positive.
Area of Science:
- Neonatal Intensive Care
- Pediatric Critical Care Medicine
- Cardiopulmonary Support
Background:
- Refractory hypoxemia in newborns presents a significant clinical challenge, often necessitating advanced life support.
- Extracorporeal membrane oxygenation (ECMO) provides a critical intervention for neonates with severe respiratory or cardiac failure.
- Understanding the long-term prognosis of infants treated with ECMO is essential for guiding clinical management and parental counseling.
Purpose of the Study:
- To evaluate the long-term prognosis of newborn infants experiencing refractory hypoxemia who required extracorporeal membrane oxygenation (ECMO).
- To identify factors influencing survival and morbidity in this high-risk neonatal population.
- To specifically assess outcomes for infants with congenital diaphragmatic hernia (CDH) compared to other diagnoses.
Main Methods:
- An observational cohort study included 89 newborn infants requiring ECMO for over 24 hours between 1996 and 2003.
- Infants were followed up at 9 months and 24 months post-treatment.
- Data collected included primary diagnosis, duration of ECMO, survival rates, oxygen dependency, feeding status, and neurodevelopmental outcomes.
Main Results:
- Overall survival to hospital discharge was 67%. Meconium aspiration syndrome (MAS) had the highest survival rate (82%), while congenital diaphragmatic hernia (CDH) had the lowest (46%).
- Among survivors, oxygen dependency decreased significantly over time, with only one infant requiring oxygen at 2 years.
- CDH infants experienced prolonged oxygen and tube feeding durations, and initially poorer neurological acquisition, but showed favorable neurodevelopmental evolution by 24 months.
Conclusions:
- Morbidity in ECMO survivors is relatively low given the severity of their initial illness, with pulmonary and feeding issues being the primary concerns in the early months.
- The long-term prognosis for infants with CDH treated with ECMO is generally favorable regarding growth and neurodevelopmental outcomes by age two.
- ECMO is an effective therapy for severe neonatal respiratory failure, offering a positive outlook for most survivors, particularly those with MAS.
Objectives:
To assess the prognosis of newborn infants with refractory hypoxemia who required extracorporeal membrane oxygenation (ECMO).
Methods:
Eighty-nine newborn infants treated by ECMO during more than 24 hours over a 8-year period (1996-2003) were included in this observational cohort study with a 9-month and 24-month evaluation.
Results:
Respiratory failure mainly resulted from meconium aspiration syndrome (MAS, 43%), congenital diaphragmatic hernia (CDH, 15%) and sepsis (15%). Overall survival at hospital discharge was 67%. Infants with MAS had the best survival rate (82%) and those with CDH had the worst (46%). Of the remaining 60 survivors, 53% remained oxygen dependent at 28 days and 33% at 45 days. At the age of 2 years, only 1 infant remained oxygen dependent (but did not required oxygen at 3 years) and only 3 infants had significant neurodevelopmental problems. CDH group was associated with a prolonged duration in supplementary oxygen (P<0.001) and a prolonged duration for tube feeding (P=0.01) as compared with other diagnoses. Regarding neurologic outcome, CDH infants had the poorer neurological acquisition rate at 9 months but a very good evolution by the time of the 24-month evaluation.
Conclusions:
Morbidity in ECMO survivors is low considering the severity of illness in the newborn period, mainly related to pulmonary and feeding dysfunctions during the first months, in particular for the CDH group. Outcome at the age of 2 years of CDH infants is most often favourable regarding growth and neurodevelopmental evolution.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Endotracheal Tube Extubation
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals.
Cardiopulmonary Resuscitation II: ACLS Airway Management
Acute Respiratory Failure-III
Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
